05 August 202605 August 2026If proved effective, UNAIDS highlights that speed, affordability and equitable access will be critic... If the trials are successful, this development could provide another tool in the HIV prevention toolbox and a positive step towards ending AIDS. MSD has announced voluntary licensing agreements with generic pharmaceutical manufacturers, including three in Africa, to produce the once-monthly oral HIV prevention candidate. No one should have to wait years for life-saving HIV prevention." It will also bring innovative HIV prevention options closer to the people who need them most, supported by sustainable market development and technology transfer.